BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23599315)

  • 1. The ecology of human papillomavirus-induced epithelial lesions and the role of somatic evolution in their progression.
    Orlando PA; Brown JS; Gatenby RA; Guliano AR
    J Infect Dis; 2013 Aug; 208(3):394-402. PubMed ID: 23599315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with the oncogenic human papillomavirus type 59 alters protein components of the cornified cell envelope.
    Lehr E; Brown DR
    Virology; 2003 Apr; 309(1):53-60. PubMed ID: 12726726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial cell responses to infection with human papillomavirus.
    Stanley MA
    Clin Microbiol Rev; 2012 Apr; 25(2):215-22. PubMed ID: 22491770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothetic association between human papillomavirus infection and breast carcinoma.
    Liang W; Tian H
    Med Hypotheses; 2008; 70(2):305-7. PubMed ID: 17656036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillomavirus infections--a major cause of human cancers.
    zur Hausen H
    Biochim Biophys Acta; 1996 Oct; 1288(2):F55-78. PubMed ID: 8876633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS].
    Lopukhov PD; Briko NI; Khaldin AA; Tsapkova NN; Lupashko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):71-8. PubMed ID: 27029121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy.
    Cavatorta AL; Fumero G; Chouhy D; Aguirre R; Nocito AL; Giri AA; Banks L; Gardiol D
    Int J Cancer; 2004 Sep; 111(3):373-80. PubMed ID: 15221964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
    Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
    mBio; 2016 May; 7(3):. PubMed ID: 27143385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
    Graham SV
    Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women.
    Cañadas MP; Videla S; Darwich L; Tarrats A; Piñol M; García-Cuyás F; Llatjos M; Alcalde C; Fernández I; Sirera G; Clotet B
    J Clin Virol; 2010 Jul; 48(3):198-201. PubMed ID: 20427229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry.
    Ozbun MA
    Papillomavirus Res; 2019 Jun; 7():188-192. PubMed ID: 30981651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue.
    Agrawal N; Mane M; Chiriva-Internati M; Roman JJ; Hermonat PL
    Virology; 2002 Jun; 297(2):203-10. PubMed ID: 12083819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative response of normal and of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene.
    Melikian AA; Wang X; Waggoner S; Hoffmann D; El-Bayoumy K
    Oncol Rep; 1999; 6(6):1371-6. PubMed ID: 10523714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
    Fehrmann F; Laimins LA
    Oncogene; 2003 Aug; 22(33):5201-7. PubMed ID: 12910257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.
    Shamanin V; zur Hausen H; Lavergne D; Proby CM; Leigh IM; Neumann C; Hamm H; Goos M; Haustein UF; Jung EG; Plewig G; Wolff H; de Villiers EM
    J Natl Cancer Inst; 1996 Jun; 88(12):802-11. PubMed ID: 8637046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11.
    Kreider JW; Howett MK; Stoler MH; Zaino RJ; Welsh P
    Int J Cancer; 1987 Apr; 39(4):459-65. PubMed ID: 3030939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
    Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
    Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infections and oral tumors.
    Syrjänen S
    Med Microbiol Immunol; 2003 Aug; 192(3):123-8. PubMed ID: 12920585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.